Skip to content
ppharmaranks
Menu

Best Benzodiazepine for epilepsies, partial

Top-rated pick: Lorazepam — pharmaranks score 70/100, the highest of the 5 Benzodiazepine drugs used for epilepsies, partial, ranked by our independent FDA recall-safety score. Compare them with all treatments for epilepsies, partial or the full Benzodiazepine class. Not medical advice — always consult a professional.

Quick answer: Of the 5 benzodiazepine drugs we rate for epilepsies, partial, 3 are available as lower-cost generics, and most are injectable. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for epilepsies, partial; the right choice depends on your situation, so confirm it with your prescriber.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

How benzodiazepine work

Benzodiazepines boost the brain's main calming chemical, GABA, by binding to the GABA-A receptor and making its chloride channel open more often. This quiets nerve activity, producing sedation, reduced anxiety, muscle relaxation, and protection against seizures.

Source: Benzodiazepines — StatPearls, NCBI Bookshelf (NIH)

Other drug classes for epilepsies, partial

Top benzodiazepine for epilepsies, partial: 1. Lorazepam · 2. Ativan · 3. Loreev XR

Best-rated Benzodiazepine for epilepsies, partial, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100$1View →
268/100$1View →
3Not yet rated$1View →
4Not yet ratedView →
5Not yet ratedView →

Full ranking · 5 drugs

Frequently asked

What is the best benzodiazepine for epilepsies, partial?
By our independent recall-safety rating — not an efficacy measure — lorazepam ranks highest among Benzodiazepine drugs used for epilepsies, partial. Always consult a professional.
Which benzodiazepine drugs treat epilepsies, partial?
pharmaranks lists 5 Benzodiazepine products used for epilepsies, partial, per NIH RxClass drug-classification data — each independently rated and ranked above.
How are these ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.